Summary The number of macules is usually registered at diagnosis in the first clinical examination of leprosy patients. The question studied here is whether this practice is of any interest as an indicator of the precocity of detection or the prognosis. The study is based on the 26,996 paucibacillary patients detected from 1957 to 1982 in Polambakkam Leprosy Centre (South India) for whom the number of macules and disability status are assessed and registered.
to the number of macules at detection, this information could only be worth reporting ifit can help to build either: a more sensitive indicator of early detection than the proportion of patients with disabilities among the newly detected cases; or an indicator of prognosis, either for the duration of treatment until inactivation of the lesions, or for the risk of relapse.
Thus this study has two objectives. First, to study whether the proportion of single-macule patients among newly detected cases is a more sensitive indicator of early diagnosis than the presence of disability. This objective is only verified if the several-macules stage is preceded by the single-macule stage and if the delay to go from one to several macules is shorter than the delay necessary to develop disabilities. The second objective is to evaluate the prognosis value of the number of macules at detection. It will be reached by comparing inactivation and relapse probabilities between single-and several-macule patients.
Material and methods
This study is based on the data routinely collected in the Polambakkam Leprosy Control Programme, in South India, where 47,068 patients were detected between 1955 and 1982. Among these patients eligible for the present study were those:
of the paucibacillary type of the disease (either clinical tuberculoid type or borderline type with negative bacteriological status); detected from 1957 to 1982, as the first 2 years showed too many missing values regarding the number of macules at detection; never treated before; and with a number of macules and presence of disabilities both assessed at detection.
According to these criteria 26,996 patients were selected for the analysis. For the second objective, i.e. evaluation of the prognosis value of the number ofmacules, attendance to treatment had also to be known from detection to either inactivation or cure. This was the case for 26, 106 patients.
Information on the number of macules and the presence of disabilities was only registered at detection, and not at the subsequent fo llow-ups. The term 'macule' was actually used for all kinds of patches, either flat or partly or wholly elevated, that are characteristic of leprosy. The number of macules at detection was recorded in only two categories: one macule, and more than one.
Disabilities included bone lesions, claw hands, drop fe et, fa cial lesions and ulcers. Anaesthesia is not taken into account. Distinction was made between index and contacts patients. Patients living in the same household as an already registered case were considered as contacts. This distinction was necessary because: mean age may be different for the contact and the noncontact populations; the contact population is more likely to be infected; and the contact population is more frequently and regularly examined, leading to a higher probability of early detection.
Contact status was unknown for 554 patients. Standard treatment was dapsone monotherapy, to be continued after inactivation for a consolidation period whose duration was based on the WHO recommendations.6 Attendance for treatment is estimated as the number of attended sessions of treatment divided by the number of organized sessions and expressed in two groups (�75% and < 75%). Clinical status of the patients was recorded annually.
In the study area, inactivation was defined as 'complete subsidence of thickening and erythema in the patches resulting in the wrinkling and scanning of lesion with partial or complete return to sensation and complete subsidence of activity in the peripheral and trunk nerves'. Relapses concern patients who developed new signs and symptoms of the disease after stopping therapy.
To evaluate the validity of the number ofmacules at detection as an indicator of early diagnosis and prognosis, a longitudinal study would be the appropriate methodology. Unfortunately, information concerning the number ofmacules and the disabilities was registered at detection only. Consequently, for the first objective (early diagnosis) we had to make do with a cross-sectional analysis to get hints on the evolution of the number of macules. For the second objective (prognosis), data concerning clinical status was collected at yearly fo llow-ups, enabling us to perform the appropriate longitudinal study. This was based on the actuarial or life-table method. 2
Results

EARLY DIAGNOSIS
Distribution and mean age of the patients by number of macules and presence of disabilities at detection are shown in Table I . The percentage of patients with disabilities is 3·7 times higher in the several-macule than in the single-macule patients. The difference of mean age observed between several and single-macule patients (1,8-3'9 years) is much smaller than the one observed between patients with and without disabilities (10'5-12·6 years). Mean age for each disability status, is lower for the single than for the several-macule patients. This observation is verified throughout the whole period for both index and contact groups, as shown in Figure I . Due to small numbers, the distinction between index and contact was not possible for the patients with disabilities. Tables 2 and 3 show the distribution of the patients by number of macules, presence of disabilities and contact status. The proportion of several-macule patients is similar for both index and contact groups, while the proportion of patients with disabilities in the index group is two times higher than in the contact group. Figure 2 describes the trends of proportions of single-macule and disabled patients among newly detected cases, from 1957 to 1982. The irregularities observed in 1960 in both curves reflect the extension of the leprosy control area, with a sudden detection of many old cases. For both curves, a significant slope could be demonstrated, using a logistic regression from 1961 onwards (p <0·00 1 for the disabilities and p <O· OO I for the macules). Ye ars Figure 2 . Annual evolution of the percentages of single-macule patients and of patients with disability.
PROGNOSIS
Whatever their number of macules, patients with good attendance to treatment inactivate sooner than patients with poor attendance (Figure 3 ). Within each group of attendance, single-macule patients inactivate sooner than several-macule patients. Figure 4 shows relapse probabilities after inactivation by number of macules at detection. These probabilities are lower for single-macule patients, even after a long observation period. This is still true when results are displayed by attendance to treatment ( Figure 5 ). Delay (years) Figure 4 . Cumulative relapse probabilities after inactivation, by number of macules at detection.
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Discussion
EARLY DIAGNOSIS
The proportion of disabled among newly detected cases is widely accepted as an indicator of early diagnosis,s early detected patients having a lower probability of presenting disabilities. Repeated observations3.4 showed that the proportion of disabled patients decreases with the improvement of detection activities. For the proportion of single-macule patients among newly detected cases to be also accepted as an indicator of early diagnosis, the several-macule stage should be preceded by a single-macule stage. With the limitations of a cross-sectional study, one would then expect to make the fo llowing observations: a higher proportion of single-macule patients among the patients without disability than among those with disabilities; an increasing proportion of single-macule patients when the proportion of disabled among newly detected cases decreases over time; a lower mean age at detection for the single-macule than for the several-macule patients; and a higher proportion of single-macule patients among the contacts than among the index, since the contact population is more frequently examined, and consequently detected earlier;
The actual observations reported in Tables I to 3 and Figures I and 2 , are consistent with the expectations. One could object that the same observation could be made if the number ofmacules at detection was determined by the age at onset rather than by the delay between onset and detection, younger patients being more prone to develop only one macule. This can be refuted by the fact that the several-macule contacts are younger than the single-macule index patients. The significance of this observation is fu rther enforced by its consistency throughout the study period. The proportion of single-macule among newly detected cases may thus be considered as an indicator of early diagnosis. Even if valid as an indicator, the proportion of single-macule patients is worth reporting only if it is more sensitive than the proportion of disabled patients.
Because disabilities take a long time to develop, the proportion of patients with disabilities can evidence changes in detection activities only after a long delay. Moreover, after many years, the group of disabled patients is usually so small that minimal random variations in their number lead to great changes in the proportion.
In Table I , we observe that the difference of mean age between several-and single-macule patients is much smaller than the difference observed between patients with and without disabilities. In Table 3 , the proportion of disabled among contacts is two times less than among index cases, due to contacts being examined more freq uently. On the contrary, the proportion of single-macule patients is almost similar for both groups. These two observations are consistent with a shorter delay for the development of several macules than the delay needed to experience disabilities. Thus it seems that the proportion of single-macule patients among newly detected cases is a more sensitive indicator of precocity of detection than the proportion of patients with disabilities. The proportion of single-macule patients would be an especially helpful indicator for programmes running for several years, when it becomes difficult to observe significant variations of the proportion of patients with disabilities.
There are however two difficulties attached to the use of an indicator based on the number of macules. First, a more careful clinical examination, and thus a more experienced staff, is needed to assess the number of macules than to detect disabilities. Second, it is based on paucibacillary patients only. However, if detection occurs progressively earlier for paucibacillary leprosy, it seems only logical to think that it evolves likewise for multi bacillary leprosy.
PROGNOSIS
The second objective of the study was to evaluate the prognosis value of the number of macules at detection on inactivation and relapse probabilities. Figure 3 shows that single-macule patients inactivate sooner than several-macule patients. The proportion of self-healing cases is probably higher in the first group, but that does not modify the prognosis value of the number ofmacules. It is however quite satisfactory to observe that regularity to treatment is a better predictor of early inactivation than the number of macules. However, one limitation of the study is the insufficient power of discrimination of the classification used for the macules-several macules just means 'more than one'. It is possible that a more detailed classification would give more gradual and convincing differences in inactivation probabilities. Figures 4 and 5 show that the number of macules is an important predictor of relapse probability, more so than the regularity to treatment. The number of macules at detection depends on, at least, two fa ctors: the delay between onset of the disease and its detection; and the immune defences of the patients. While several-macule patients all have relatively poor immunity, the single-macule patients include those with poor immunity but early detected, together with patients who have good immunity. That could explain why, their immune defences on average being better, patients with single macule seem relatively protected against relapses. Regarding inactivation, though, the immune status has less influence on the necessary duration of treatment than the compliance to treatment.
The implications of these observations on multidrug therapy (MDT) are certainly worth studying. If the same results were observed after MDT, the selection of the MDT regimen and its duration should then be based not only on bacteriological, but also on clinical criteria.
